Clinical Trials Logo
  1. Home
  2. Pregnancy
  3. NCT03452215
  4. Details
NCT03452215 Clinical Trial

Mobile Application and Pregnant Patient Knowledge

Pregnancy Clinical Trial

Official title:
Impact of Mobile Application on Patient Knowledge of Pregnancy Topics

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT03452215
Other study ID # 01-18-30
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 9, 2018
Est. completion date June 30, 2019

Study information
Verified date June 2020
Source University Hospitals Cleveland Medical Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Randomized controlled trial to investigate the impact of a pregnancy-specific mobile phone application on the knowledge of specific pregnancy topics and guidelines.

Recruitment information / eligibility
Status Completed
Enrollment 15
Est. completion date June 30, 2019
Est. primary completion date May 31, 2019
Accepts healthy volunteers No
Gender Female
Age group 16 Years and older
Eligibility Inclusion Criteria:

- 18 years of age or older at time of consent (or 16-17 years of age with guardian present)

- Singleton gestation

Exclusion Criteria:

- Inadequate knowledge of English language

- Inability to read at or above 8th grade level

- Prior diagnosis of eating disorder

Study Design

Related Conditions & MeSH terms

Intervention

Behavioral:
• Mobile Phone Application Educational Resources
Mobile Phone Application Educational Resources
• Mobile Phone Application GWG Tracker
Mobile Phone Application GWG Tracker

Locations
Country Name City State
United States University Hospitals Cleveland Ohio

Sponsors (1)
Lead Sponsor Collaborator
University Hospitals Cleveland Medical Center

Country where clinical trial is conducted

United States, 

Outcome
Type Measure Description Time frame Safety issue
Primary Pregnancy-specific topic/guideline questionnaire Number of participants who correctly answer Outcome assessed up to 23 weeks gestation
Secondary Pregnancy-specific questionnaire Description of general patient population knowledge of pregnancy-specific topics and guidelines. Outcome assessed up to 23 weeks gestation
Secondary Gestational weight gain quantification Quantify total gestational weight gain with and without intervention from final documented weight during pregnancy. Outcome assessed through study completion, an average of 7 months
See also
  Status Clinical Trial Phase
Completed NCT03442582 - Afluria Pregnancy Registry
Terminated NCT02161861 - Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study N/A
Not yet recruiting NCT05934318 - L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE) N/A
Enrolling by invitation NCT05415371 - Persistent Poverty Counties Pregnant Women With Medicaid N/A
Completed NCT04548102 - Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman N/A
Completed NCT03218956 - Protein Requirement During Lactation N/A
Completed NCT02191605 - Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy N/A
Completed NCT02223637 - Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
Recruiting NCT06049953 - Maternal And Infant Antipsychotic Study
Completed NCT02577536 - PregSource: Crowdsourcing to Understand Pregnancy
Not yet recruiting NCT06336434 - CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy Phase 1/Phase 2
Not yet recruiting NCT04786587 - Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
Not yet recruiting NCT05412238 - Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months N/A
Not yet recruiting NCT05028387 - Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
Completed NCT02683005 - Study of Hepatitis C Treatment During Pregnancy Phase 1
Completed NCT02783170 - Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women Phase 4
Recruiting NCT02564250 - Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women N/A
Recruiting NCT02619188 - Nutritional Markers in Normal and Hyperemesis Pregnancies N/A
Recruiting NCT02507180 - Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
Completed NCT02408315 - Induction With Misoprostol: Oral Mucosa Versus Vaginal Epithelium (IMPROVE) Phase 3